Compare Stocks: OPK, LFST, CRVL, and OPCH

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CRVL CorVel	$75.60 +1.4%	$67.45	$44.83 ▼ $79.43	$3.86B	0.97	218,703 shs	49,471 shs
LFST LifeStance Health Group	$11.99 -0.3%	$12.03	$4.77 ▼ $13.56	$4.58B	1.22	3.69 million shs	1.39 million shs
OPCH Option Care Health	$22.68 +0.8%	$23.53	$18.01 ▼ $36.80	$3.40B	0.61	2.45 million shs	566,738 shs
OPK OPKO Health	$1.58 -2.2%	$1.49	$0.98 ▼ $1.75	$1.18B	1.5	2.96 million shs	1.06 million shs

10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CRVL CorVel	+0.11%	+1.71%	+8.23%	+16.23%	-3.71%
LFST LifeStance Health Group	+1.18%	-0.41%	-2.67%	+6.74%	+118.73%
OPCH Option Care Health	-1.40%	-3.64%	-4.09%	+2.69%	-18.98%
OPK OPKO Health	-0.62%	-5.29%	+9.52%	+5.92%	+3.87%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CRVL CorVel	$75.60 +1.4%	$67.45	$44.83 ▼ $79.43	$3.86B	0.97	218,703 shs	49,471 shs
LFST LifeStance Health Group	$11.99 -0.3%	$12.03	$4.77 ▼ $13.56	$4.58B	1.22	3.69 million shs	1.39 million shs
OPCH Option Care Health	$22.68 +0.8%	$23.53	$18.01 ▼ $36.80	$3.40B	0.61	2.45 million shs	566,738 shs
OPK OPKO Health	$1.58 -2.2%	$1.49	$0.98 ▼ $1.75	$1.18B	1.5	2.96 million shs	1.06 million shs

10 Best Stocks to Own in Fall 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CRVL CorVel	+0.11%	+1.71%	+8.23%	+16.23%	-3.71%
LFST LifeStance Health Group	+1.18%	-0.41%	-2.67%	+6.74%	+118.73%
OPCH Option Care Health	-1.40%	-3.64%	-4.09%	+2.69%	-18.98%
OPK OPKO Health	-0.62%	-5.29%	+9.52%	+5.92%	+3.87%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CRVL CorVel	2.00	Hold	N/A	N/A
LFST LifeStance Health Group	2.73	Moderate Buy	$12.88	7.38% Upside
OPCH Option Care Health	2.50	Moderate Buy	$29.92	31.93% Upside
OPK OPKO Health	2.33	Hold	$1.55	-1.59% Downside

Current Analyst Ratings Breakdown

Latest OPK, LFST, CRVL, and OPCH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/28/2026	OPK OPKO Health	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
9/22/2026	OPCH Option Care Health	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
9/11/2026	OPCH Option Care Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D+) ➝ Hold (C-)
9/10/2026	LFST LifeStance Health Group	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$13.00 ➝ $15.00
9/9/2026	LFST LifeStance Health Group	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$13.00 ➝ $15.00
9/1/2026	CRVL CorVel	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
8/27/2026	OPCH Option Care Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D+)
8/19/2026	LFST LifeStance Health Group	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$16.00 ➝ $18.00
8/14/2026	LFST LifeStance Health Group	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$9.00 ➝ $13.00
8/13/2026	OPK OPKO Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
8/11/2026	LFST LifeStance Health Group	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)

(Data available from 10/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CRVL CorVel	$958.53M	4.02	$2.82 per share	26.81	$7.71 per share	9.81
LFST LifeStance Health Group	$1.42B	3.22	$0.17 per share	70.68	$3.91 per share	3.07
OPCH Option Care Health	$5.65B	0.60	$2.03 per share	11.16	$8.36 per share	2.71
OPK OPKO Health	$606.90M	1.94	N/A	N/A	$1.67 per share	0.94

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CRVL CorVel	$110.34M	$2.25	33.61	N/A	N/A	11.72%	29.92%	17.82%	11/3/2026 (Estimated)
LFST LifeStance Health Group	$9.66M	$0.13	92.24	52.13	N/A	3.19%	3.39%	2.33%	11/5/2026 (Estimated)
OPCH Option Care Health	$207.59M	$1.33	17.06	12.00	1.31	3.68%	18.74%	7.25%	10/29/2026 (Estimated)
OPK OPKO Health	-$225.68M	-$0.09	N/A	N/A	N/A	-12.40%	-5.88%	-3.83%	11/4/2026 (Estimated)

Latest OPK, LFST, CRVL, and OPCH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
10/29/2026	Q3 2026	OPCH Option Care Health	$0.4871	N/A	N/A	N/A	$1.47 billion	N/A
8/6/2026	Q2 2026	LFST LifeStance Health Group	$0.0328	$0.06	+$0.0273	$0.06	$414.58 million	$435.35 million
8/4/2026	Q1 2027	CRVL CorVel	N/A	$0.63	N/A	$0.63	N/A	$259.93 million
7/29/2026	Q2 2026	OPCH Option Care Health	$0.4263	$0.45	+$0.0237	$0.35	$1.42 billion	$1.44 billion
7/27/2026	Q2 2026	OPK OPKO Health	-$0.08	-$0.01	+$0.07	-$0.01	$131.23 million	$163.58 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CRVL CorVel	N/A	N/A	N/A	N/A	N/A
LFST LifeStance Health Group	N/A	N/A	N/A	N/A	N/A
OPCH Option Care Health	N/A	N/A	N/A	N/A	N/A
OPK OPKO Health	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CRVL CorVel	N/A	1.94	1.94
LFST LifeStance Health Group	0.18	1.38	1.38
OPCH Option Care Health	0.91	1.47	0.98
OPK OPKO Health	0.28	3.35	2.93

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CRVL CorVel	51.36%
LFST LifeStance Health Group	85.50%
OPCH Option Care Health	98.05%
OPK OPKO Health	64.63%

Insider Ownership

Company	Insider Ownership
CRVL CorVel	39.72%
LFST LifeStance Health Group	3.50%
OPCH Option Care Health	1.70%
OPK OPKO Health	44.72%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CRVL CorVel	5,239	51.01 million	30.75 million	Optionable
LFST LifeStance Health Group	10,961	382.15 million	368.78 million	Optionable
OPCH Option Care Health	8,266	149.79 million	147.24 million	Optionable
OPK OPKO Health	1,373	746.33 million	412.57 million	Optionable

OPK, LFST, CRVL, and OPCH Headlines

Recent News About These Companies

OPKO Health (NASDAQ:OPK) Stock Rating Upgraded by Zacks Research

September 30 at 8:12 AM | marketbeat.com

Here's Why You Should Retain OPK Stock in Your Portfolio for Now

September 28 at 12:55 PM | zacks.com

Here's Why You Should Retain OPK Stock in Your Portfolio for Now

September 28 at 12:51 PM | finance.yahoo.com

OPKO Health (NASDAQ:OPK) Hits New 12-Month High - Still a Buy?

September 24, 2026 | americanbankingnews.com

Die OPKO-Health-Aktie profitiert 2026 von solider Nachfrage und Finanzierungsspielraum

September 23, 2026 | ad-hoc-news.deA

Opko Health股價創52週新高，觸及1.74美元

September 23, 2026 | hk.investing.com

OPKO Health (NASDAQ:OPK) Reaches New 12-Month High - Should You Buy?

September 22, 2026 | marketbeat.com

OPK Stock Climbs 32.5% YTD: What's Driving the Rally in 2026?

September 21, 2026 | finance.yahoo.com

OPK Stock Climbs 32.5% YTD: What's Driving the Rally in 2026?

September 21, 2026 | zacks.com

OPKO Health stock gains support from improved Q2 2026 results

September 19, 2026 | ad-hoc-news.deA

OPKO Health (NASDAQ:OPK) Shares Pass Above 50-Day Moving Average - Should You Sell?

September 19, 2026 | marketbeat.com

The Bull Case For OPKO Health (OPK) Could Change Following New Mazdutide Royalty-Backed Financing Strategy

September 15, 2026 | finance.yahoo.com

OPKO Health (OPK) Cashes In A Future Royalty Stream Early

September 13, 2026 | finance.yahoo.com

OPKO Health (OPK) Cashes In A Future Royalty Stream Early

September 13, 2026 | insidermonkey.com

OPKO Health Pivots to Therapeutics, Eyes Data-Rich 12 to 18 Months

September 11, 2026 | marketbeat.com

OPKO Health op Wells Fargo-conferentie: cashrijke verschuiving naar therapeutica

September 10, 2026 | nl.investing.com

OPKO Health, Inc. (OPK)

September 9, 2026 | finance.yahoo.com

Bank of New York Mellon Corp Takes Position in OPKO Health, Inc. $OPK

September 9, 2026 | marketbeat.com

OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference

September 8, 2026 | finance.yahoo.com

OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference

September 8, 2026 | globenewswire.com

OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Rating of "Hold" by Brokerages

September 8, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

OPK, LFST, CRVL, and OPCH Company Descriptions

CorVel NASDAQ:CRVL

$75.60 +1.05 (+1.41%)

As of 01:48 PM Eastern

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.

LifeStance Health Group NASDAQ:LFST

$11.98 -0.05 (-0.37%)

As of 01:49 PM Eastern

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Option Care Health NASDAQ:OPCH

$22.68 +0.19 (+0.85%)

As of 01:49 PM Eastern

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

OPKO Health NASDAQ:OPK

$1.58 -0.04 (-2.17%)

As of 01:49 PM Eastern

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest OPK, LFST, CRVL, and OPCH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest OPK, LFST, CRVL, and OPCH Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

OPK, LFST, CRVL, and OPCH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

OPK, LFST, CRVL, and OPCH Company Descriptions

CorVel NASDAQ:CRVL

LifeStance Health Group NASDAQ:LFST

Option Care Health NASDAQ:OPCH

OPKO Health NASDAQ:OPK

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest OPK, LFST, CRVL, and OPCH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest OPK, LFST, CRVL, and OPCH Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

OPK, LFST, CRVL, and OPCH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

OPK, LFST, CRVL, and OPCH Company Descriptions

CorVel NASDAQ:CRVL

LifeStance Health Group NASDAQ:LFST

Option Care Health NASDAQ:OPCH

OPKO Health NASDAQ:OPK

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools